Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples